4
Changes in Ownership
Hypha Labs, Inc. Filed Acc 0001493152-20-003754
Options or other derivatives
- Chief Executive Officer acquired 750,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Remenda Kyle Chief Executive Officer | 2020-03-09 | Grant or award · Stock Option (Right to buy) | +750,000 | 750,000 | D | ||
Loading xslF345X03/ownership.xml…